
Epilepsy and the genome
We know that epilepsy can have a genetic cause, but there is still much to discover. We explore findings from two new studies to learn more

RNAi: a new approach to combat cholesterol
The new cholesterol drug inclisiran is currently making headlines after being approved for use in the NHS, but how does it work?

New data diversity initiative launches
This week, we look at a transformative programme that aims to rapidly make genomic datasets more representative

Screening the healthy for monogenic variants
As the NHS moves towards a preventative healthcare strategy, will genomic screening for healthy people become more common?

Parkinson's disease: understanding the cause
In light of new research, we explore the role genes and their products can play in the onset of Parkinson’s disease

Cell-free DNA: detecting disease
We look at how cfDNA could be used to diagnose LMD – a life-threatening condition that is currently difficult to detect

Covid-19: susceptibility and the genome
An international collaboration has discovered new links between our genome and the variable onset and severity of Covid-19

NHS targets better diabetes care with genomic testing
New initiative aims to find thousands of people with a rare, inherited form of diabetes

Newborn screening: time for a genomic approach?
This week, we explore how genomics could help expand the newborn screening programme to test for many more genetic conditions

PCR: more than just a Covid test
An old friend has been thrust into the limelight. We take a look at how PCR works and its place in Covid testing and beyond

Trial underway for hATTR therapy
The novel ‘one off’ treatment could change the lives of those living with the condition

Combating cancer: POLQ inhibitors
We explore a novel treatment that could help treat cancer by preventing DNA repair in tumours